Medical and surgical management of Myasthenia Gravis - Chaari, Zied
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, responsible for the production of autoantibodies against acetylcholine receptors in striated skeletal muscle. This is responsible for the appearance of fluctuating muscular fatigue which, when generalized, can be life-threatening. The association of myasthenia seen in thymic pathology was first described in 1901 by Laquer, and medical treatment (essentially including drugs to increase neuromuscular transmission, immunosuppressants, immunoglobulins, monoclonal antibodies or plasma exchange) is often combined…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, responsible for the production of autoantibodies against acetylcholine receptors in striated skeletal muscle. This is responsible for the appearance of fluctuating muscular fatigue which, when generalized, can be life-threatening. The association of myasthenia seen in thymic pathology was first described in 1901 by Laquer, and medical treatment (essentially including drugs to increase neuromuscular transmission, immunosuppressants, immunoglobulins, monoclonal antibodies or plasma exchange) is often combined with surgical management to achieve simple or enlarged thymectomy.The earlier a patient undergoes thymectomy, the better the outcome in terms of post-thymectomy morbidity and mortality. This book outlines the medical and surgical management of MG.
Autorenporträt
Dr. Zied CHAARIThoraxchirurg seit 2015 und seit 2021 Maître de Conférences Agrégé en Chirurgie Thoracique am CHU Habib Bourguiba in Sfax-Tunesien. Er hat zwei Jahre lang in französischen Krankenhäusern (Paris und CHU Charles Nicolle in Rouen) gearbeitet. Mitglied der Association Tunisienne de Chirurgie Thoracique et Cardiovasculaire (ATCTCV).